Literature DB >> 23400708

Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease.

Berislav V Zlokovic1.   

Abstract

Human apolipoprotein E (apoE) has 3 isoforms: apoE2, apoE3, and apoE4. APOE4 is a major genetic risk factor for Alzheimer disease and is associated with dementia in Down syndrome and poor neurological outcome after traumatic brain injury, cerebral hemorrhage, and other neuropathological disorders. While apoE4 can induce neuropathology by participating in various cellular and molecular pathways, herein I review data supporting the hypothesis that apoE4 has direct toxic effects on the cerebrovascular system that in turn can lead to secondary neuronal dysfunction and degeneration as well as accumulation of neurotoxins in brain such as β-amyloid (Aβ) in Alzheimer disease. I review Aβ-independent cerebrovascular effects of apoE, particularly activation of a proinflammatory cyclophilin A-mediated pathway in brain vascular pericytes by apoE4 that has recently been shown to lead to a loss of cerebrovascular integrity and blood-brain barrier breakdown causing neuronal injury. I also review Aβ-dependent cerebrovascular effects of apoE such as faulty Aβ clearance from brain to circulation by apoE4. Finally, I discuss isoform-specific interactions of apoE with low-density lipoprotein receptor-related protein 1 on brain vascular cells (ie, endothelial cells, pericytes), which play an important role in Aβ-independent and Aβ-dependent effects of apoE on cerebral vasculature.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23400708      PMCID: PMC4414030          DOI: 10.1001/jamaneurol.2013.2152

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  17 in total

1.  Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.

Authors:  B D Zipser; C E Johanson; L Gonzalez; T M Berzin; R Tavares; C M Hulette; M P Vitek; V Hovanesian; E G Stopa
Journal:  Neurobiol Aging       Date:  2006-06-16       Impact factor: 4.673

2.  Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.

Authors:  Robert D Bell; Ethan A Winkler; Abhay P Sagare; Itender Singh; Barb LaRue; Rashid Deane; Berislav V Zlokovic
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

3.  Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.

Authors:  Joseph M Castellano; Jungsu Kim; Floy R Stewart; Hong Jiang; Ronald B DeMattos; Bruce W Patterson; Anne M Fagan; John C Morris; Kwasi G Mawuenyega; Carlos Cruchaga; Alison M Goate; Kelly R Bales; Steven M Paul; Randall J Bateman; David M Holtzman
Journal:  Sci Transl Med       Date:  2011-06-29       Impact factor: 17.956

Review 4.  Apolipoprotein E in Alzheimer's disease and other neurological disorders.

Authors:  Philip B Verghese; Joseph M Castellano; David M Holtzman
Journal:  Lancet Neurol       Date:  2011-03       Impact factor: 44.182

5.  Central nervous system pericytes in health and disease.

Authors:  Ethan A Winkler; Robert D Bell; Berislav V Zlokovic
Journal:  Nat Neurosci       Date:  2011-10-26       Impact factor: 24.884

6.  APOE and Alzheimer disease: a major gene with semi-dominant inheritance.

Authors:  E Genin; D Hannequin; D Wallon; K Sleegers; M Hiltunen; O Combarros; M J Bullido; S Engelborghs; P De Deyn; C Berr; F Pasquier; B Dubois; G Tognoni; N Fiévet; N Brouwers; K Bettens; B Arosio; E Coto; M Del Zompo; I Mateo; J Epelbaum; A Frank-Garcia; S Helisalmi; E Porcellini; A Pilotto; P Forti; R Ferri; E Scarpini; G Siciliano; V Solfrizzi; S Sorbi; G Spalletta; F Valdivieso; S Vepsäläinen; V Alvarez; P Bosco; M Mancuso; F Panza; B Nacmias; P Bossù; O Hanon; P Piccardi; G Annoni; D Seripa; D Galimberti; F Licastro; H Soininen; J-F Dartigues; M I Kamboh; C Van Broeckhoven; J C Lambert; P Amouyel; D Campion
Journal:  Mol Psychiatry       Date:  2011-05-10       Impact factor: 15.992

7.  Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.

Authors:  Robert D Bell; Abhay P Sagare; Alan E Friedman; Gurrinder S Bedi; David M Holtzman; Rashid Deane; Berislav V Zlokovic
Journal:  J Cereb Blood Flow Metab       Date:  2006-11-01       Impact factor: 6.200

8.  Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  J Lipid Res       Date:  2008-12-22       Impact factor: 5.922

9.  apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.

Authors:  Rashid Deane; Abhay Sagare; Katie Hamm; Margaret Parisi; Steven Lane; Mary Beth Finn; David M Holtzman; Berislav V Zlokovic
Journal:  J Clin Invest       Date:  2008-11-13       Impact factor: 14.808

Review 10.  The role of apolipoprotein E in Alzheimer's disease.

Authors:  Jungsu Kim; Jacob M Basak; David M Holtzman
Journal:  Neuron       Date:  2009-08-13       Impact factor: 17.173

View more
  107 in total

1.  In Vivo Imaging of Venous Side Cerebral Small-Vessel Disease in Older Adults: An MRI Method at 7T.

Authors:  C E Shaaban; H J Aizenstein; D R Jorgensen; R L MacCloud; N A Meckes; K I Erickson; N W Glynn; J Mettenburg; J Guralnik; A B Newman; T S Ibrahim; P J Laurienti; A N Vallejo; C Rosano
Journal:  AJNR Am J Neuroradiol       Date:  2017-08-03       Impact factor: 3.825

Review 2.  Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.

Authors:  Puneet Talwar; Juhi Sinha; Sandeep Grover; Chitra Rawat; Suman Kushwaha; Rachna Agarwal; Vibha Taneja; Ritushree Kukreti
Journal:  Mol Neurobiol       Date:  2015-09-09       Impact factor: 5.590

Review 3.  Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.

Authors:  Mrinmay Chakrabarti; Alexander J McDonald; J Will Reed; Melissa A Moss; Bhaskar C Das; Swapan K Ray
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 4.  SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases.

Authors:  Ross W Paterson; Audrey Gabelle; Brendan P Lucey; Nicolas R Barthélemy; Claire A Leckey; Christophe Hirtz; Sylvain Lehmann; Chihiro Sato; Bruce W Patterson; Tim West; Kevin Yarasheski; Jonathan D Rohrer; Norelle C Wildburger; Jonathan M Schott; Celeste M Karch; Selina Wray; Timothy M Miller; Donald L Elbert; Henrik Zetterberg; Nick C Fox; Randall J Bateman
Journal:  Nat Rev Neurol       Date:  2019-06-20       Impact factor: 42.937

5.  Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway.

Authors:  Caroline S Casey; Yuka Atagi; Yu Yamazaki; Mitsuru Shinohara; Masaya Tachibana; Yuan Fu; Guojun Bu; Takahisa Kanekiyo
Journal:  J Biol Chem       Date:  2015-04-22       Impact factor: 5.157

Review 6.  [Genetics of dementia].

Authors:  J Diehl-Schmid; K Oexle
Journal:  Nervenarzt       Date:  2015-07       Impact factor: 1.214

7.  ApoE and pulse pressure interactively influence level and change in the aging of episodic memory: Protective effects among ε2 carriers.

Authors:  G Peggy McFall; Sandra A Wiebe; David Vergote; David Westaway; Jack Jhamandas; Lars Bäckman; Roger A Dixon
Journal:  Neuropsychology       Date:  2014-12-01       Impact factor: 3.295

8.  Human apolipoprotein E ɛ4 expression impairs cerebral vascularization and blood-brain barrier function in mice.

Authors:  Wael Alata; Yue Ye; Isabelle St-Amour; Milène Vandal; Frédéric Calon
Journal:  J Cereb Blood Flow Metab       Date:  2014-10-22       Impact factor: 6.200

Review 9.  Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.

Authors:  Barry Boland; Wai Haung Yu; Olga Corti; Bertrand Mollereau; Alexandre Henriques; Erwan Bezard; Greg M Pastores; David C Rubinsztein; Ralph A Nixon; Michael R Duchen; Giovanna R Mallucci; Guido Kroemer; Beth Levine; Eeva-Liisa Eskelinen; Fanny Mochel; Michael Spedding; Caroline Louis; Olivier R Martin; Mark J Millan
Journal:  Nat Rev Drug Discov       Date:  2018-08-17       Impact factor: 84.694

10.  Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly.

Authors:  Florence F Roussotte; Boris A Gutman; Sarah K Madsen; John B Colby; Paul M Thompson
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.